In addition to the significant clinical relevance, miR-193a-5p- and miR-188-5p-regulated CCND1-RNASEL-CDKN1A-TP73-MDM2-UBE2I signaling may be a novel regulatory biomodule within prostate carcinogenesis. Here, MDM2 is linked to male reproductive organ cancer.